Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | 0 | uM | 10 | 2500.00 | 1067.09 | 5385.00 | 5401.50 | 0.9970 | 0.9974 | |
MDA-MB-231 | Erlotinib | 3.1623 | uM | 10 | 2500.00 | 1067.09 | 5123.00 | 5401.50 | 0.9484 | 0.9553 |
MDA-MB-231 | Lapatinib | 0.0016596 | uM | 10 | 2500.00 | 1067.09 | 5076.00 | 5401.50 | 0.9397 | 0.9476 |
MDA-MB-231 | Linsitinib | 1 | uM | 10 | 2500.00 | 1067.09 | 5043.00 | 5401.50 | 0.9336 | 0.9422 |
MDA-MB-231 | Lapatinib | 3.1623 | uM | 10 | 2500.00 | 1067.09 | 5162.00 | 5401.50 | 0.9557 | 0.9616 |
MDA-MB-231 | Linsitinib | 0.0033113 | uM | 10 | 2500.00 | 1067.09 | 5876.00 | 5401.50 | 1.0878 | 1.0733 |
MDA-MB-231 | 17-AAG | 0.31623 | uM | 10 | 2500.00 | 1067.09 | 5476.00 | 5401.50 | 1.0138 | 1.0117 |
MDA-MB-231 | 17-AAG | 0.01 | uM | 10 | 2500.00 | 1067.09 | 5370.00 | 5401.50 | 0.9942 | 0.9950 |
MDA-MB-231 | Lapatinib | 1 | uM | 10 | 2500.00 | 1067.09 | 5022.00 | 5401.50 | 0.9297 | 0.9387 |
MDA-MB-231 | Erlotinib | 0.0033113 | uM | 10 | 2500.00 | 1067.09 | 5104.00 | 5401.50 | 0.9449 | 0.9522 |
MDA-MB-231 | Erlotinib | 0.31623 | uM | 10 | 2500.00 | 1067.09 | 5323.00 | 5401.50 | 0.9855 | 0.9875 |
MDA-MB-231 | Lapatinib | 0.31623 | uM | 10 | 2500.00 | 1067.09 | 4993.00 | 5401.50 | 0.9244 | 0.9339 |
MDA-MB-231 | Erlotinib | 10 | uM | 10 | 2500.00 | 1067.09 | 4902.00 | 5401.50 | 0.9075 | 0.9188 |
MDA-MB-231 | Erlotinib | 19.9526 | uM | 10 | 2500.00 | 1067.09 | 3718.00 | 5401.50 | 0.6883 | 0.7049 |
MDA-MB-231 | 17-AAG | 0.0033113 | uM | 10 | 2500.00 | 1067.09 | 5384.00 | 5401.50 | 0.9968 | 0.9972 |
MDA-MB-231 | Lapatinib | 10 | uM | 10 | 2500.00 | 1067.09 | 4425.00 | 5401.50 | 0.8192 | 0.8366 |
MDA-MB-231 | 0 | uM | 10 | 2500.00 | 1067.09 | 5241.00 | 5401.50 | 0.9703 | 0.9744 | |
MDA-MB-231 | 0 | uM | 10 | 5000.00 | 2314.91 | 6347.00 | 6524.00 | 0.9729 | 0.9635 | |
MDA-MB-231 | Linsitinib | 0.01 | uM | 10 | 5000.00 | 2314.91 | 6471.00 | 6524.00 | 0.9919 | 0.9891 |
MDA-MB-231 | Linsitinib | 0.031623 | uM | 10 | 5000.00 | 2314.91 | 6448.00 | 6524.00 | 0.9884 | 0.9844 |
MDA-MB-231 | 0 | uM | 10 | 5000.00 | 2314.91 | 6490.00 | 6524.00 | 0.9948 | 0.9930 | |
MDA-MB-231 | 17-AAG | 1 | uM | 10 | 5000.00 | 2314.91 | 6026.00 | 6524.00 | 0.9237 | 0.8965 |
MDA-MB-231 | Linsitinib | 10 | uM | 10 | 5000.00 | 2314.91 | 5616.00 | 6524.00 | 0.8608 | 0.8092 |
MDA-MB-231 | 17-AAG | 0.1 | uM | 10 | 5000.00 | 2314.91 | 6504.00 | 6524.00 | 0.9969 | 0.9959 |
MDA-MB-231 | Lapatinib | 0.01 | uM | 10 | 5000.00 | 2314.91 | 6523.00 | 6524.00 | 0.9999 | 0.9998 |